PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Tackling cognitive deficits in Alzheimer's disease: 1 'STEP' at a time

2010-10-19
(Press-News.org) Lowering levels of a key protein involved in regulating learning and memory—STtriatal-Enriched tyrosine Phosphatase (STEP)—reversed cognitive deficits in mice with Alzheimer's disease, Yale School of Medicine researchers report in the October 18 issue of Proceedings of the National Academy of Sciences.

"This finding provides a rationale for drug discovery and for developing therapeutic agents that could inhibit STEP proteins and might improve the outlook for Alzheimer's disease patients," said senior author of the study Paul Lombroso, M.D., professor in the Yale Child Study Center and in the Departments of Neurobiology and Psychiatry at Yale School of Medicine.

To test the idea that lowering STEP levels might reverse cognitive deficit in Alzheimer's disease, Lombroso and a team that included Nobel laureate Paul Greengard of Rockefeller University conducted a study on mice that were genetically engineered to still have the Alzheimer's mutation, but without the STEP protein. They compared these animals to mice with only the Alzheimer's mutation in a series of memory tests including a water maze. Mice without the STEP protein learned the maze after a 10-day training period, but the Alzheimer's mice did not. "This tells us that reducing STEP levels is sufficient to reverse the cognitive defect in these mice," said Lombroso.

Lombroso discovered the STEP protein in earlier studies. Past research has shown that increased STEP levels are caused by the toxic peptide beta amyloid that blocks an organelle programmed to destroy these proteins. "When that organelle is inhibited, proteins, including STEP won't be degraded and will accumulate," said Lombroso.

Lombroso said that glutamate receptors on the surface of neurons are key to learning and memory. He and his team determined that the excess level of STEP was removing these glutamate receptors and preventing short-term memories from turning into long-term memories.

In addition to Alzheimer's disease, increased levels of STEP in the brain have been implicated in other disorders such as schizophrenia and Fragile X, which is characterized by cognitive deficits and other disabilities. Once again, high levels of STEP proteins remove glutamate receptors from synapses and contribute to the cognitive deficits present in these diseases.

"These new findings need to be replicated, but if genetically reducing STEP levels is improving cognition, we could perhaps discover a drug designed to reduce STEP activity," said Lombroso. "Our current work is focused on looking for STEP inhibitors."

INFORMATION:

The study was funded by the American Health Assistance Foundation.

Other authors on the study include Yongfang Zhang, Pradeep Kurup, Jian Xu, Nikisha Carty, Stephanie Fernandez, Haakon B. Nygaard, Christopher Pittenger, Stephen M. Strittmatter and Angus C. Nairn.

Citation: PNAS doi/10.1073/pnas.1013543107

END



ELSE PRESS RELEASES FROM THIS DATE:

Beta carotene and retinitis pigmentosa

2010-10-19
CHICAGO—Today's Scientific Program of the 2010 American Academy of Ophthalmology (AAO) - Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene's ability to improve vision in people with certain incurable retinal diseases. The AAO-MEACO meeting–the world's largest, most comprehensive ophthalmic education conference–is in session October 16 through 19 at McCormick Place, Chicago. 9-cis Beta-Carotene Mat Boost Vision in Some Patients with Incurable Retinal Disease Retinitis pigmentosa (RP) is a cluster of hereditary disorders ...

New evidence of the power of open access

2010-10-19
New findings settle one of the arguments about Open Access (OA) research publications: Are they more likely to be cited because they were made OA, or were they made OA because they were more likely to be cited? The study, which will be published in PLoS ONE on the first day of Open Access Week (18 October), was carried out by a bi-national team of researchers from the University of Southampton's School of Electronics and Computer Science (ECS) in the UK and l'Université du Québec à Montréal in Canada. The results show that the OA citation impact advantage is just ...

Surgical complications drop at hospitals that share patient safety data

2010-10-19
ANN ARBOR, Mich. – Michigan hospitals reduced surgical complications by nearly 10 percent at a time when the rest of the nation saw no change in complication rates, according to a new study out next week in the Archives of Surgery. Complications dropped at hospitals participating in what's called the Michigan Surgical Quality Collaborative, a group of 16 hospitals led by the University of Michigan Health System that agreed to pool data and share information about what keeps patients safe. The fewer patients suffering ventilator associated pneumonias alone, among the ...

News and insights in gastroenterology presented at the ACG's 75th Annual Meeting

2010-10-19
Bethesda, Maryland (October 14, 2010) – Many of the world's preeminent gastroenterologists will gather for the American College of Gastroenterology's (ACG) 75th Annual Scientific Meeting at the Henry B. Gonzalez Convention Center in San Antonio, Texas starting Monday October 18, 2010, to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management. Innovative technologies for the diagnosis and treatment of digestive diseases; insights into digestive health conditions, their causes and how they impact ...

Allergy drug found to clear condition but not symptoms of throat disease

2010-10-19
ROCHESTER, Minn. -- A group of Mayo Clinic (http://www.mayoclinic.org/about/) researchers conducted the first controlled trial of swallowed fluticasone nasal spray (also known as Flonase) on people with the allergic esophageal condition called eosinophilic esophagitis (http://www.mayoclinic.org/eosinophilic-esophagitis/). Research showed that the aerosolized swallowed allergy drug helped treat the cause of the throat condition, but symptoms lingered. The researchers' findings were presented today at the Annual Scientific Meeting of the American College of Gastroenterology ...

The protein NOS2 isn't good for ER-negative breast cancer patients

2010-10-19
Breast cancers can be divided into different subtypes based on several criteria, including whether or not they express the protein to which the female hormone estrogen binds; that is, the estrogen receptor (ER). Patients with ER-negative breast tumors have a worse outlook than those with ER-positive breast tumors. However, even among ER-negative breast tumors, those characterized as basal-like are the most aggressive and difficult to treat. New therapeutic targets for this subtype of breast cancer are urgently needed. Now, a team of researchers, led by Stefan Ambs, at the ...

JCI online early table of contents: Oct. 18, 2010

2010-10-19
EDITOR'S PICK: The protein NOS2 isn't good for ER-negative breast cancer patients Breast cancers can be divided into different subtypes based on several criteria, including whether or not they express the protein to which the female hormone estrogen binds; that is, the estrogen receptor (ER). Patients with ER-negative breast tumors have a worse outlook than those with ER-positive breast tumors. However, even among ER-negative breast tumors, those characterized as basal-like are the most aggressive and difficult to treat. New therapeutic targets for this subtype of breast ...

Medicare hospital comparison website may not help patients locate best places for high-risk surgery

2010-10-19
Information available on a government Web site designed to help patients choose high-quality hospitals does not appear to help Medicare beneficiaries identify facilities with better outcomes for high-risk surgeries, according to a report in the October issue of Archives of Surgery, one of the JAMA/Archives journals. In an effort to reduce variations in surgical quality, the Centers for Medicare and Medicaid Services (CMS) now requires hospitals to report data from the national Surgical Care Improvement Project involving measures taken to prevent infection and blood clots, ...

Psychiatric illnesses before surgery associated with modest increased risk of death afterward

2010-10-19
Individuals with co-occurring psychiatric illnesses, especially anxiety and depression, appear to have an increased risk of death within 30 days of surgery, according to a report in the October issue of Archives of Surgery, one of the JAMA/Archives journals. Psychiatric illnesses occur along with physical complaints in an estimated 5 percent to 40 percent of hospitalized patients, according to background information in the article. Having a psychiatric condition is independently associated with an increased risk of illness and death. Previous studies of these conditions ...

Study examines factors associated with seeking skin cancer screening

2010-10-19
A survey of patients undergoing skin cancer screening shows that women were more likely to seek screening because of a skin lesion, a family history of skin cancer, or concern about sun exposure, whereas men age 50 and older, a group at highest risk for melanoma, may only seek screenings after a previous skin cancer diagnosis, according to a report in the October issue of Archives of Dermatology, one of the JAMA/Archives journals. In 2008, more than 62,000 Americans were diagnosed with the skin cancer melanoma and almost 8,500 died from the disease, according to background ...

LAST 30 PRESS RELEASES:

Community partners key to success of vaccine clinic focused on neurodevelopmental conditions

Low-carbon collaborative dual-layer optimization for energy station considering joint electricity and heat demand response

McMaster University researchers uncover potential treatment for rare genetic disorders

The return of protectionism: The impact of the Sino-US trade war

UTokyo and NARO develop new vertical seed distribution trait for soybean breeding

Research into UK’s use of plastic packaging finds households ‘wishcycle’ rather than recycle – risking vast contamination

Vaccine shows promise against aggressive breast cancer

Adverse events affect over 1 in 3 surgery patients, US study finds

Outsourcing adult social care has contributed to England’s care crisis, argue experts

The Lancet: Over 800 million adults living with diabetes, more than half not receiving treatment, global study suggests

New therapeutic approach for severe COVID-19: faster recovery and reduction in mortality

Plugged wells and reduced injection lower induced earthquake rates in Oklahoma

Yin selected as a 2024 American Society of Agronomy Fellow

Long Covid could cost the economy billions every year

Bluetooth technology unlocks urban animal secrets

This nifty AI tool helps neurosurgeons find sneaky cancer cells

Treatment advances, predictive biomarkers stand to improve bladder cancer care

NYC's ride-hailing fee failed to ease Manhattan traffic, new NYU Tandon study reveals

Meteorite contains evidence of liquid water on Mars 742 million years ago

Self-reported screening helped reduce distressing symptoms for pediatric patients with cancer

Which risk factors are linked to having a severe stroke?

Opening borders for workers: Abe’s profound influence on Japan’s immigration regime

How skills from hospitality and tourism can propel careers beyond the industry

Research shows managers of firms handling recalls should review media scrutiny before deciding whether to lobby

New model system for the development of potential active substances used in condensate modifying drugs

How to reduce social media stress by leaning in instead of logging off

Pioneering research shows sea life will struggle to survive future global warming

In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery 

Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023

Repurposing semaglutide and liraglutide for alcohol use disorder

[Press-News.org] Tackling cognitive deficits in Alzheimer's disease: 1 'STEP' at a time